Latest filing published 28 Nov 2022 for Vaccinex, INC., €97k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jacob B. Frieberg: trading record in brief
All filings by Jacob B. Frieberg on record concern Vaccinex, Inc., in the capacity of board member. We count 6 filings; the first trade dates from 23 January 2020 and the latest from 23 November 2022.
On the market, this insider has only ever bought: 2 purchases, €269k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. Since January 2022: 1 purchase and no sales on the market.
The record was last updated on 28 November 2022 with a share grant (€97k) in Vaccinex, Inc. The most recent open-market purchase was published on 31 January 2022, 1,744 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jacob B. Frieberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 188,928 shares@ US$0.529335.3% of flowCommon StockSEC:0001062993-22-022814:0
- 90,090 shares@ US$1.1147.8% of flowCommon StockSEC:0001062993-22-001868:0Canonical exit: 27 Apr 2022 (T+90)
- 4,420 sharesCommon StockSEC:0000891839-21-000234:0
3 of 3 declarations